Literature DB >> 2393259

Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.

R Dworkin1, G Modin, S Kunz, R Rich, O Zak, M Sande.   

Abstract

The efficacies of the quinolones ciprofloxacin and pefloxacin alone and in combination with rifampin were compared with those of vancomycin alone and in combination with rifampin in a rat model of chronic osteomyelitis caused by methicillin-resistant Staphylococcus aureus. Neither the quinolones nor vancomycin alone was effective in reducing titers of organisms in bone after therapy, while rifampin alone was effective. All combination regimens with rifampin were more effective than the regimen with rifampin alone was, although these differences did not achieve statistical significance. Rifampin-resistant isolates were detected rarely. Quinolone-rifampin combination regimens may offer a nonparenteral option for the treatment of chronic osteomyelitis caused by methicillin-resistant S. aureus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393259      PMCID: PMC171748          DOI: 10.1128/AAC.34.6.1014

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.

Authors:  N K Henry; M S Rouse; A L Whitesell; M E McConnell; W R Wilson
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

2.  Emergence of rifampin-resistant strains of Staphylococcus aureus during combination therapy with vancomycin and rifampin: a report of two cases.

Authors:  G L Simon; R H Smith; M A Sande
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

3.  Rifampin: mechanisms of action and resistance.

Authors:  W Wehrli
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

4.  Model of experimental chronic osteomyelitis in rats.

Authors:  J P Rissing; T B Buxton; R S Weinstein; R K Shockley
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

5.  Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin.

Authors:  C W Norden; M Shaffer
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

6.  Experimental chronic staphylococcal osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents.

Authors:  C W Norden
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

7.  Rifampin resistance. Development during the therapy of methicillin-resistant Staphylococcus aureus infection.

Authors:  R H Eng; S M Smith; M Tillem; C Cherubin
Journal:  Arch Intern Med       Date:  1985-01

8.  Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis.

Authors:  J Black; T L Hunt; P J Godley; E Matthew
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

9.  In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs.

Authors:  R J Fass; V L Helsel
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

10.  Treatment of acute osteomyelitis in childhood.

Authors:  W G Cole; R E Dalziel; S Leitl
Journal:  J Bone Joint Surg Br       Date:  1982
View more
  26 in total

1.  Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis.

Authors:  Paschalis Vergidis; Mark S Rouse; Gorane Euba; Melissa J Karau; Suzannah M Schmidt; Jayawant N Mandrekar; James M Steckelberg; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

2.  Antimicrobial therapy for bone and joint infections.

Authors:  Saima Aslam; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

3.  Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection.

Authors:  O Murillo; M E Pachón; G Euba; R Verdaguer; F Tubau; C Cabellos; J Cabo; F Gudiol; J Ariza
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

4.  Osteomyelitis management: More art than science?

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-03       Impact factor: 2.471

5.  In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Authors:  D Bahl; D A Miller; I Leviton; P Gialanella; M J Wolin; W Liu; R Perkins; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

6.  Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection.

Authors:  A C Crémieux; A S Mghir; R Bleton; M Manteau; N Belmatoug; L Massias; L Garry; N Sales; B Mazière; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

7.  Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics.

Authors:  C Chuard; P Vaudaux; F A Waldvogel; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.

Authors:  G P Voorn; J Kuyvenhoven; W H Goessens; W C Schmal-Bauer; P H Broeders; J Thompson; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

9.  Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin.

Authors:  T O'Reilly; S Kunz; E Sande; O Zak; M A Sande; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

10.  Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers.

Authors:  M P Weinstein; R G Deeter; K A Swanson; J S Gross
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.